Fmoc-Glu-ODmab

Fmoc-Glu-ODmab is an Fmoc-protected glutamic acid derivative bearing a side-chain carboxyl group masked as an ODmab (ODmab = dimethyl acetal/amide-type carboxyl protection motif) functionality, yielding a chiral amino acid building block with defined stereochemistry at the alpha carbon. The molecule contains an Fmoc carbamate on the amino group, a free or protected carboxyl functionality depending on the ODmab group behavior, and a side-chain carbonyl equivalent that can be unmasked under conditions compatible with peptide synthesis workflows. The presence of the bulky, acid-labile or condition-responsive ODmab protection strategy moderates side-chain reactivity during coupling steps while preserving the glutamate topology required for orthogonally controlled peptide construction. The resulting protected amino acid intermediate is engineered for stepwise peptide assembly, subsequent deprotection to regenerate glutamate functionality, and downstream derivatization chemistry centered on carboxylate reactivity.

1. Peptide Synthesis

Fmoc-Glu-ODmab is used in solid-phase peptide synthesis and automated peptide assembly where glutamate incorporation requires orthogonal side-chain protection to prevent undesired side reactions during chain elongation. The Fmoc-protected alpha-amino group supports standard Fmoc deprotection and peptide coupling cycles, while the ODmab-masked side-chain carboxyl group can remain controlled during activation and amide bond formation. The glutamate side-chain geometry enables formation of peptide sequences that preserve native-like charge placement after side-chain unmasking. The compound therefore functions as a protected glutamic acid building block for generating peptide intermediates and final peptide products requiring controlled glutamate side-chain availability.

2. Side-Chain Functionalization

Fmoc-Glu-ODmab is applied in amino acid derivatization and side-chain transformation workflows where the glutamate carboxyl functionality serves as a handle for further chemical modification. The ODmab protection strategy provides a means to suppress premature carboxyl reactivity during earlier steps, then enable conversion to a free carboxylate for coupling to amines, alcohols, or activated electrophiles. The Fmoc group also supports staged exposure of functional groups, enabling sequential functionalization strategies that align with peptide or polymer conjugation schedules. The resulting downstream products can include carboxyl-activated intermediates, ester or amide derivatives, and carboxylate-bearing peptidomimetic scaffolds used in chemical biology and materials-oriented synthesis.

3. Chemical Biology Probes

Fmoc-Glu-ODmab is suitable for chemical biology research requiring incorporation of glutamate residues into labeled peptides, affinity ligands, or substrate analogs with controlled side-chain chemistry. The protected glutamate architecture enables synthesis of peptides that can later be converted to a reactive carboxylate for conjugation to dyes, linkers, or capture reagents under conditions that maintain peptide integrity. The defined stereochemistry at the alpha carbon supports faithful recognition by binding partners that discriminate stereochemical and spatial features of acidic residues. The compound can be employed to prepare peptide-based probes where glutamate positioning and side-chain reactivity are tuned for subsequent labeling and analytical detection.

4. Peptidomimetics And SAR

Fmoc-Glu-ODmab is used in peptidomimetic construction and structure-activity relationship studies where glutamate-like side-chain placement influences conformational preferences and interaction profiles. The Fmoc-protected backbone supports rapid assembly of analog libraries, while the ODmab-protected side-chain carboxyl group supports controlled generation of acidic functionality for incorporation into SAR-focused series. The ability to unmask the side-chain carboxylate after peptide assembly enables late-stage diversification into amides, esters, or carboxylate derivatives used to probe binding and transport hypotheses. The compound thus serves as a practical amino acid derivative for generating systematic glutamate-containing analogs and related synthetic intermediates for medicinal chemistry research.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-Glu-ODmab is relevant to pharmaceutical manufacturing and fine chemical production workflows that rely on reproducible, protected amino acid inputs for controlled peptide or peptide-derived intermediate manufacture. The Fmoc carbamate and side-chain protection strategy support consistent coupling behavior across batch processing, while the ODmab-masked carboxyl group helps manage chemoselectivity during assembly of glutamate-containing sequences. The compound's design as a chiral, protected amino acid intermediate supports downstream deprotection and conversion steps that regenerate glutamate functionality for further processing into drug substance precursors or quality-controlled intermediates. The resulting manufactured intermediates can be directed toward peptide-based active ingredient candidates, process development studies, and scale-up-compatible synthetic routes in applied peptide chemistry.

1. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

3. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

5. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury